Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06446622 · ClinicalTrials.gov registry record · NA
Brain Blood Flow Responses During Exercise: Younger Cohort
A NA study of Magnetic Resonance Imaging and Cerebrovascular Circulation, sponsored by University of Wisconsin, Madison.
- Active
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT06446622: Active NA study of Magnetic Resonance Imaging and Cerebrovascular Circulation, sponsored by University of Wisconsin, Madison.
NCT06446622 is a NA study of Magnetic Resonance Imaging and Cerebrovascular Circulation that is active but no longer recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 45 participants, below the 156-participant average among 20 other Magnetic Resonance Imaging trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06446622, a NA study of Magnetic Resonance Imaging and Cerebrovascular Circulation, is active but no longer recruiting, sponsored by University of Wisconsin, Madison.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
Brain blood flow will be measured during exercise using magnetic resonance imaging.
Primary Outcome
The change in cross-sectional area of the cerebral arteries during exercise will be measured with MRI.
Conditions Studied
Interventions
- DEVICE MRI
Study Locations (1)
Wisconsin
- University of Wisconsin-Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2023-04-18 |
| Est. Completion | 2026-07 |
| Phase | NA |
What the registry record for NCT06446622 still lists
NCT06446622 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 156-participant average among 20 other Magnetic Resonance Imaging trials with a reported enrollment target (71% lower).
The record links to 2 conditions, with Magnetic Resonance Imaging appearing as the primary indexed condition, and to 1 intervention - of which MRI is the first listed.
NCT06446622 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06446622 about?
NCT06446622 is a clinical study titled "Brain Blood Flow Responses During Exercise: Younger Cohort". Brain blood flow will be measured during exercise using magnetic resonance imaging.
What is the current status of trial NCT06446622?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2023-04-18. Estimated completion is 2026-07.
What conditions does trial NCT06446622 study?
This clinical trial studies the following conditions: Magnetic Resonance Imaging, Cerebrovascular Circulation.
What interventions are being tested in trial NCT06446622?
The interventions under investigation include: MRI (DEVICE).
Who is sponsoring clinical trial NCT06446622?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06446622 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Magnetic Resonance Imaging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06446622's enrollment target sits among peer trials
45 14th of 20 higher than 7 of 20 other Magnetic Resonance Imaging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Magnetic Resonance Imaging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort
RECRUITING · NA
-
Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0
RECRUITING · NA
-
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
RECRUITING · NA
-
Serial MRI Scans During Radiation Therapy
RECRUITING · NA
-
Brain Stimulation for Concussion
ACTIVE NOT RECRUITING · NA
-
Brain Blood Flow Responses During Exercise
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI